ArticleOPEN ACCESS

A CAR against CAR for unintended consequences

Blood
DOI: 10.1182/blood.2019004172
0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Ruella and colleagues report the development of a chimeric antigen receptor (CAR) that could target anti-CD19 CAR T cells (CAR191 T) used for therapy of B-cell malignancies as well as leukemic B cells inadvertently transduced with anti-CD19 CAR (CAR191 B).1

Cite

CITATION STYLE

APA

Neelapu, S. S. (2020, February 13). A CAR against CAR for unintended consequences. Blood. American Society of Hematology. https://doi.org/10.1182/blood.2019004172

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free